VNRX - VolitionRx Limited (VNRX) CEO Cameron Reynolds on Q1 2022 Results - Earnings Call Transcript

VolitionRx Limited (VNRX) Q1 2022 Results Conference Call May 12, 2022 08:30 AM ET Company Participants Scott Powell - Executive Vice President of Investor Relations Cameron Reynolds - President and Chief Executive Officer Tom Butera - Chief Executive Officer, Volition Veterinary Diagnostics Development Terig Hughes - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Presentation Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited's First Quarter 2022 Earnings Conference Call. During today's presentation, all parties will be in a listen-only mode. Following the presentation, the conference call will be open for questions. [Operator Instructions] This conference is being recorded today, May 12, 2022. And now, I would now like to turn the conference call over to Scott Powell, Executive Vice President of Investor Relations. Please go ahead. Scott Powell Thank you, and welcome, everyone, to today's earnings conference call for VolitionRx

For further details see:

VolitionRx Limited (VNRX) CEO Cameron Reynolds on Q1 2022 Results - Earnings Call Transcript